Kim Kardashian's Instagram Post About Morning Sickness Drug Diclegis Lands Her In Trouble With FDA

Why Is Kim K In Hot Water With The FDA?

Kim Kardashian has landed herself in some hot water with the FDA, over a selfie she posted on Instagram, endorsing a drug she claimed helped her morning sickness.

READ MORE:

Last month, Kim uploaded a photo to her Instagram page, in which she was holding a bottle of Diclegis, a morning sickness aid intended to help pregnant women.

She wrote: “As you guys know my#morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor.

This post has since vanished from Kim's page

“He prescribed me#Diclegis, I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby. I’m so excited and happy with my results that I’m partnering with Duchesnay USA to raise awareness about treating morning sickness.”

At the time, she came under fire from some of her followers for backing a pharmaceutical brand, with many asking how much she was paid to back the drug.

However, the post has now faced an even bigger backlash, with the Food and Drug Administration insisting the pregnant reality TV star remove the post from her social media page.

Kim Kardashian

The FDA stated that Kim's post “misleading”, adding that it failed to mention the potential side effects or downsides of the pill, insisting she had included “repeated” violations of medicine advertising laws.

Earlier this week, Kim responded to accusations that she was secretly using a surrogate and “faking” her pregnancy, in a typically Kim K fashion, by uploading a naked selfie to show the world her pregnant body.

Close

What's Hot